-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $64

Benzinga·06/04/2026 13:25:18
Listen to the news
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $85 to $64.